Skip to search formSkip to main contentSkip to account menu

Right arm

Known as: RA, Right brachial region, Arm.right 
The portion of the upper extremity between the shoulder and the wrist and located on the right side of the body.
National Institutes of Health

Related topics

Related topics

7 relations
Body structure ICF code:Find:Pt:^Patient:NomRight biceps brachiiRight brachial arteryUpper Extremity

Narrower (2)

Right median nerveRight upper arm structure

Broader (1)

Upper arm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials…
BACKGROUND Previous studies suggest that nonnucleoside reverse-transcriptase inhibitors (NNRTIs) cause faster virologic… 
2013
2013
Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study.
OBJECTIVES Raltegravir has been demonstrated to have a favourable impact on several metabolic parameters, including a lack of… 
2013
2013
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial
Abstract Background: The objective of this study was to compare the efficacy of ritonavir boosted atazanavir versus ritonavir… 
2013
2013
Quantitative positron emission tomography imaging of angiogenesis in rats with forelimb ischemia using 68Ga-NOTA-c(RGDyK)
Gallium-68-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)—cyclic Arg-Gly-Asp-D-Tyr-Lys (c(RGDyK)) was developed for… 
2011
2011
Beneficial effects of a switch to a Lopinavir/ritonavir-containing regimen for patients with partial or no immune reconstitution with highly active antiretroviral therapy despite complete viral…
The purpose of this study was to determine if switching to an Lopinavir/ritonavir (LPV/r)-containing regimen resulted in greater… 
Highly Cited
2009
Highly Cited
2009
Ultrasensitive assessment of residual HIV viraemia in HAART‐treated patients with persistently undetectable plasma HIV‐RNA: A cross‐sectional evaluation
Improvements in HIV‐RNA assays have made accurate detection of as few as 2 copies/ml possible. This study objective was the… 
2008
2008
Validation of a portable hand-held lactate analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda.
To the Editor: In a recent issue of AIDS, Dr. Walmsley et al analyzed HIV RNA responses to treatment in the tipranavir/ ritonavir… 
2008
2008
Long-term Efficacy and Safety of Abacavir/Lamivudine (ABC/3TC) with Fosamprenavir + Ritonavir (FPV/r) Versus Lopinavir/Ritonavir (LPV/r) over 144 Weeks
The KLEAN study 48 wk data established that FPV/r combination treatment is non-inferior to LPV/r over 48 wks when used with the… 
2007
2007
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV‐infected patients who failed treatment with nonnucleoside reverse transcriptase…
Long‐term nonnucleoside reverse transcriptase inhibitor (NNRTI)‐based antiretroviral treatment failure in most developing… 
2004
2004
Case report of neuroendocrine carcinoma of the skin, histochemical and electron microscopic study
A rare case of neuroendocrine carcinoma of the skin in a 83-year-old male Japanese was reported. Histological, electron… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)